Physician profile
Gregory Mark Rogers
NPI 1609875673
$3,831.08
in general payments reported to CMS, 2019-2025
37 companies · $563 in 2025
The $563 reported for 2025 was more than what 75% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $676 · 2020: $691 · 2021: $1,104 · 2023: $171 · 2024: $626 · 2025: $563.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,359 · Education: $0.79.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,359.46 |
| Education | $0.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $420.43 | 2020-2025 | Vraylar, Ubrelvy |
| Pfizer INC. | $394.64 | 2019-2025 | |
| Astellas Pharma US INC | $275.40 | 2019-2021 | |
| Amarin Pharma, INC. | $243.26 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $239.87 | 2019-2025 | Jardiance |
| Janssen Pharmaceuticals, INC | $213.67 | 2019-2021 | |
| Novo Nordisk INC | $194.85 | 2020-2025 | Rybelsus, Ozempic |
| Astrazeneca Pharmaceuticals LP | $170.46 | 2019-2025 | Airsupra |
| Sumitomo Pharma America, INC. | $169.86 | 2023-2025 | Gemtesa |
| Novartis Pharmaceuticals Corporation | $167.95 | 2019-2024 | |
| Amgen INC. | $139.02 | 2019-2024 | Evenity, Prolia |
| Axsome Therapeutics, INC. | $131.88 | 2024-2025 | Auvelity |
| Glaxosmithkline, LLC. | $128.90 | 2019-2021 | |
| Exact Sciences Corporation | $123.81 | 2024-2025 | Cologuard Collection Kit |
| Lilly USA, LLC | $103.11 | 2019-2025 | Mounjaro, Zepbound |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Rogers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.